Showing results (41-50 of 148) with videos related to
Sort By:
Pageof 15
Journal of Neural Transmission (Vienna, Austria : 1996)|April 9, 2022
Botulinum toxin therapy: past, present and future developmentsDirk Dressler, Eric A JohnsonJournal of Clinical Movement Disorders|May 4, 2017
Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapyDirk Dressler, Fereshte Adib SaberiToxicology|October 3, 2022
The immunology of botulinum toxin therapy: A brief summaryDirk Dressler, Hans Bigalke, Jürgen FrevertMovement Disorders : Official Journal of the Movement Disorder Society|August 4, 2005
Mouse diaphragm assay for detection of antibodies against botulinum toxin type BDirk Dressler, M Lange, Hans BigalkeJournal of Neural Transmission (Vienna, Austria : 1996)|October 6, 2011
Measuring the potency labelling of onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin (®)) in an LD50 assayDirk Dressler, Gerd Mander, Klaus FinkJournal of Neural Transmission (Vienna, Austria : 1996)|May 5, 2026
Therapeutic botulinum toxin preparations: an updateHans Bigalke, Jürgen Frevert, Dirk DresslerJournal of Neurology|August 21, 2003
Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failureDirk Dressler, Hans Bigalke, Reiner BeneckeJournal of the Neurological Sciences|November 5, 2019
More than hemifacial spasm? A case of unilateral facial spasms with systematic review of red flagsJirada Sringean, Dirk Dressler, Roongroj BhidayasiriJournal of Neural Transmission (Vienna, Austria : 1996)|June 28, 2018
Comparing incobotulinumtoxinA (Xeomin®) and onabotulinumtoxinA (Botox®): identical potency labelling in the hemidiaphragm assayDirk Dressler, Lizhen Pan, Hans BigalkeBrain Sciences|August 1, 2020
Body Concept and Quality of Life in Patients with Idiopathic DystoniaLejla Paracka, Florian Wegner, Claus Escher, et al.Pageof 15